These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 3896215

  • 61. Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type.
    Irvine WJ, McCallum CJ, Gray RS, Campbell CJ, Duncan LJ, Farquhar JW, Vaughan H, Morris PJ.
    Diabetes; 1977 Feb; 26(2):138-47. PubMed ID: 320073
    [Abstract] [Full Text] [Related]

  • 62. Maturity-onset diabetes of youth in black Americans.
    Winter WE, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP.
    N Engl J Med; 1987 Feb 05; 316(6):285-91. PubMed ID: 3543673
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. Factors for development of secondary failure to sulfonylurea drugs in non-insulin-dependent diabetes mellitus.
    Borissova AM, Koev DG, Minev MG, Martinova FG, Gencova PI, Kirilov GG, Arnaudov J.
    Acta Diabetol Lat; 1991 Feb 05; 28(1):91-8. PubMed ID: 1862695
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Sustained initial remission induced by intensive insulin treatment in type I diabetes. Possible role of the genetic background.
    Vague P, Vialettes B, Lassmann V, Moulin JP, Mercier P.
    Acta Diabetol Lat; 1985 Feb 05; 22(4):295-304. PubMed ID: 3914156
    [Abstract] [Full Text] [Related]

  • 69. C-peptide in juvenile diabetes.
    Ludvigsson J, Heding LG.
    Acta Paediatr Scand Suppl; 1977 Feb 05; (270):53-62. PubMed ID: 356517
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. Discrimination of type I from insulin-treated type II diabetic patients by C-peptide measurement.
    Cravarezza P, Radaeli E, Toffoli C, Rigosa C.
    Acta Diabetol Lat; 1986 Feb 05; 23(4):345-50. PubMed ID: 3564834
    [Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. Beta cell function in insulin-treated non-insulin-dependent diabetic patients.
    Ramachandran A, Snehalatha C, Mohan V, Rao CA, Viswanathan M.
    Pancreas; 1986 Feb 05; 1(5):411-4. PubMed ID: 3550785
    [Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Prevalence of residual B-cell function related to age at onset and genetic profile in newly diagnosed type I diabetics.
    Giordano C, Galluzzo A, Pantò F, Caruso C, Bompiani G.
    Acta Diabetol Lat; 1987 Feb 05; 24(4):317-23. PubMed ID: 3326380
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Beta-cell function in pancreatic adenocarcinoma.
    Basso D, Plebani M, Fogar P, Del Favero G, Briani G, Meggiato T, Panozzo MP, Ferrara C, D'Angeli F, Burlina A.
    Pancreas; 1994 May 05; 9(3):332-5. PubMed ID: 8022755
    [Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.